Delivery Order 75N95025D00007-75N98026F00001
Award Date 6/5/26
Potential Completion Date 3/4/27
Potential Value $11K
Funding Federal Agency
Contracting Federal Agency
Ultimate Awardee
Not listed NAICS Category
Set-Aside Type
No Set-Aside Used
Federal Contract Vehicle
- Not listed
Extent Competed
Full and Open Competition
Major Defense Program
Not listed Pricing Type
Cost Plus Fixed Fee
Place of Performance
Westlake, MD 20817, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Service Contract Act
National Interest Action
Not listed Research Type
Not listed Primary Consortia Member
Not listed Similar Awards
- The National Institute on Drug Abuse (NIDA) awarded a delivery order valued at $415,717 to Technical Resources International, Inc. (TRI), a minority-owned and woman-owned small business based in Bethesda, Maryland, for a Phase I Single Ascending Dose Study under the Pharmacokinetic Analysis Resource Center program. The contract, awarded on September 10, 2024, with an ultimate completion date of March 8, 2027, represents a cost-plus-fixed-fee engagement. This delivery order was issued under...
- This is a $442,380.00 cost-plus-fixed-fee delivery order contract awarded by the National Institute on Drug Abuse (NIDA), a civilian agency, to Technical Resources International, Inc., a minority-owned, woman-owned, and Hispanic American-owned small business. The contract is for a Pharmacokinetic Analysis Resource Center to conduct a Phase I single ascending dose study from May 15, 2025 to November 14, 2026. This task order is part of a larger $545.4 million single-award Indefinite Delivery...
- This federal contract award was made by the National Institute on Drug Abuse (NIDA), a civilian agency, to Technical Resources International, Inc. (TRI), a minority-owned, woman-owned, and Hispanic American-owned small business. The $36,099 task order is for providing other support services to the Pharmacokinetic Analysis Resource Center. The contract is a cost-plus-fixed-fee delivery order with a period of performance from July 23, 2025 to July 22, 2026, and a total potential value of...
- The National Institute on Drug Abuse issued a delivery order to Eurofins Discovery Services North America, LLC on September 26, 2023, with a ceiling value of $141,140.16 under a Total Small Business set-aside for receptor binding and predictive toxicology services. The order was issued under a $5 million single-award IDIQ with NIDA for receptor binding and predictive toxicology services through September 2028. Place of performance is Bethesda, MD. The period of performance runs from September...
- The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse awarded a $74,550.00 firm fixed price delivery order to 22nd Century Technologies, Inc., a minority-owned small business. This task order is part of the larger Scientific, Operations, and Administrative Resources (SOAR) to the National Institutes of Health (NIH) indefinite-delivery, indefinite-quantity (IDIQ) contract vehicle. The order requires 22nd Century Technologies to provide...
- The National Institute on Drug Abuse (NIDA), a component of the National Institutes of Health, awarded a delivery order valued at $1.96 million to Research Triangle Institute (RTI International) for the synthesis and distribution of drugs of abuse and related compounds. This task order (TO8, N01DA-22-8944) runs from June 9, 2025 through June 8, 2026, with an ultimate completion date of June 8, 2027, and utilizes a cost-plus-fixed-fee pricing structure with no set-aside designation. The work will...
- The U.S. National Institute on Drug Abuse (NIDA), part of the Department of Health and Human Services' National Institutes of Health, awarded a $19,600.00 Purchase Order contract to Lin Jiunn, a small business located in Ambler, Pennsylvania. The contract is for a Subject Matter Expert Consultant in Drug Metabolism Pharmacokinetics (DMPK) to support NIDA's NIH Blueprint Neurotherapeutics Network program. The contract has a one-year base period with an estimated minimum of 20 annual hours and a...
- The National Institute on Drug Abuse (NIDA), a civilian agency within the U.S. Department of Health and Human Services, awarded a $120,969.12 firm-fixed-price delivery order contract to 22nd Century Technologies, Inc., a minority-owned small business. The contract is part of the Scientific, Operations, and Administrative Resources (SOAR) multiple-award indefinite-delivery/indefinite-quantity (IDIQ) contract valued at $3.6 billion, which provides a wide range of information technology products,...
- The National Institute on Drug Abuse awarded a $591,817.44 firm fixed-price delivery order to 22nd Century Technologies, Inc., a minority-owned small business headquartered in McLean, Virginia. This delivery order falls under the Scientific, Operations, and Administrative Resources (SOAR) to the National Institutes of Health master indefinite delivery/indefinite quantity (IDIQ) contract vehicle, which provides flexible, task-based support services to NIH components. The work will be performed in...
- This federal contract award with ID 75N95019D00009|75N95019F00088 was issued by the National Institute on Drug Abuse (NIDA), a civilian agency, to Technical Resources International, Inc. (Technical Resources Intl), a minority-owned, woman-owned, Hispanic American-owned small business. The purpose of this $268,664 cost-plus-fixed-fee delivery order is to conduct a Phase I study of a CBD-morphine drug-drug interaction, as outlined in the contractor's proposal. This award is not designated as a...
- 75N95025D00007Indefinite Delivery Contract
- 75N95025D00007-75N98026F00001Delivery Order
The National Institute on Drug Abuse issued a delivery order to Technical Resources International, Inc., a minority-owned, woman-owned, and Hispanic American-owned small business, with a ceiling value of $11,400 on June 5, 2026. The order is issued under NIDA's $2.5 million IDV for pharmacokinetic analysis support. This delivery order covers Task Order 4, Pharmacokinetic Analysis Resource Center, Phase III Protocol (STP7), with performance in Westlake, MD from June 5, 2026 through March 4, 2027. The work is priced on a cost-plus-fixed-fee basis with no set-aside applied.
Generated 6/4/26, 12:16 PM
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $11.4k | 6/2/26 |